"When Oxford University developed the vaccine AstraZeneca ended up owning... It was actually Bill Gates who lobbied Oxford... to say no, this has to be sold to a drug company'... so it becomes 'IP'... the Bill and Melinda Gates Foundation have been central players in ensuring that no precedent is set in the context of COVID for commercially valuable products to break the normal market-based rules on how what's called 'IP' is distributed."
